Health
Argonne’s Advanced Photon Source guided the development of new COVID-19 vaccine now in trials – News-Medical.net
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two…
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two of the variants emerging around the world. The development of this new vaccine was guided by structural information on the virus obtained at the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Argonne National Laboratory, and other light sources.
Trials are taking place at the Walter…
-
General8 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General11 hours agoAlbanese beats drum on economy as trade clouds gather
-
Business8 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
Noosa News10 hours agoSurgeon partner of former premier to testify over his patient’s death